Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.
MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23
The International Extranodal Lymphoma Study Group (IELSG) analysed a multicenter retrospective series of immunocompetent patients with PCNSL. A prognostic score resulting from the combined analysis of the independent variables is proposed in the light of its clinical relevance.
The Follicular Lymphoma International Prognostic Index (FLIPI) is a simple and reproducible prognostic index and a useful tool for improving the prognostic assessment of patients with follicular lymphoma. It can also guide treatment selection in individual patients and is used to stratify patients in prospective trials.
The International Non-Hodgkin's Lymphoma Prognostic Factor Project was undertaken to develop a model for predicting outcomes in patients with aggressive non-Hodgkin's lymphoma on the basis of the patients' clinical characteristics before treatment. Two indexes (the International Prognostic Index and age-adjusted index), were significantly more accurate than the Ann Arbor classification in predicting long-term survival.
This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.
For more detailed information on the cookies we use, please check our Privacy Policy.
Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.
